BeOne Medicines (ONC) Change in Cash (2015 - 2026)
BeOne Medicines (ONC) posted quarterly Change in Cash of $243.8 million for Q1 2026, up 325.39% year-over-year from $57.3 million in Q1 2025, and down 51.16% quarter-over-quarter from $499.1 million in Q4 2025.
BeOne Medicines (ONC) Change in Cash (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Change in Cash for 12 consecutive years, with $243.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 325.39% year-over-year to $243.8 million; the TTM figure through Mar 2026 stood at $2.3 billion (up 939.04% YoY), while the FY2025 annual figure was $2.0 billion, up 460.15% from the prior year.
- Change in Cash declined to $243.8 million in Q1 2026 per ONC's latest filing, from $499.1 million in the prior quarter.
- Across five years, Change in Cash topped out at $1.3 billion in Q3 2025 and bottomed at -$378.5 million in Q1 2024.
- Historically, Change in Cash has averaged $27.7 million across 5 years, with a median of -$74.7 million in 2024.
- Annual changes were most pronounced in 2023 — Change in Cash tumbled 1064.93% — and 2025, when it soared 1286.91%.
- BeOne Medicines' Change in Cash stood at -$325.5 million in 2022, then jumped by 132.29% to $105.1 million in 2023, then sank by 171.06% to -$74.7 million in 2024, then soared by 768.32% to $499.1 million in 2025, then plunged by 51.16% to $243.8 million in 2026.
- Business Quant data shows ONC's Change in Cash at $243.8 million in Q1 2026, $499.1 million in Q4 2025, and $1.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -170.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 427.25 Mn |
| Mar 31, 2026 | 243.78 Mn |
| Dec 31, 2025 | 499.11 Mn |
| Sep 30, 2025 | 1.32 Bn |
| Jun 30, 2025 | 255.50 Mn |
| Mar 31, 2025 | -108.16 Mn |
| Dec 31, 2024 | -74.68 Mn |
| Sep 30, 2024 | 95.50 Mn |
| Jun 30, 2024 | -189.51 Mn |
| Mar 31, 2024 | -378.55 Mn |
| Dec 31, 2023 | 105.09 Mn |
| Sep 30, 2023 | -340.68 Mn |
| Jun 30, 2023 | -122.19 Mn |
| Mar 31, 2023 | -331.27 Mn |
| Dec 31, 2022 | -325.48 Mn |
| Sep 30, 2022 | -334.90 Mn |
| Jun 30, 2022 | 180.96 Mn |
| Mar 31, 2022 | -28.44 Mn |
| Dec 31, 2021 | 3.38 Bn |
| Sep 30, 2021 | -396.99 Mn |